These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7760931)

  • 21. Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization.
    Roberts VA; Stewart J; Benkovic SJ; Getzoff ED
    J Mol Biol; 1994 Jan; 235(3):1098-116. PubMed ID: 8289310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positional ordering of reacting groups contributes significantly to the efficiency of proton transfer at an antibody active site.
    Seebeck FP; Hilvert D
    J Am Chem Soc; 2005 Feb; 127(4):1307-12. PubMed ID: 15669871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro abzyme evolution to optimize antibody recognition for catalysis.
    Takahashi N; Kakinuma H; Liu L; Nishi Y; Fujii I
    Nat Biotechnol; 2001 Jun; 19(6):563-7. PubMed ID: 11385462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Directed evolution governed by controlling the molecular recognition between an abzyme and its haptenic transition-state analog.
    Takahashi-Ando N; Kakinuma H; Fujii I; Nishi Y
    J Immunol Methods; 2004 Nov; 294(1-2):1-14. PubMed ID: 15604011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential transition-state stabilization in enzyme catalysis: quantum chemical analysis of interactions in the chorismate mutase reaction and prediction of the optimal catalytic field.
    Szefczyk B; Mulholland AJ; Ranaghan KE; Sokalski WA
    J Am Chem Soc; 2004 Dec; 126(49):16148-59. PubMed ID: 15584751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catalysis on the coastline: theozyme, molecular dynamics, and free energy perturbation analysis of antibody 21D8 catalysis of the decarboxylation of 5-nitro-3-carboxybenzisoxazole.
    Ujaque G; Tantillo DJ; Hu Y; Houk KN; Hotta K; Hilvert D
    J Comput Chem; 2003 Jan; 24(1):98-110. PubMed ID: 12483679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Off-the-shelf proteins that rival tailor-made antibodies as catalysts.
    Hollfelder F; Kirby AJ; Tawfik DS
    Nature; 1996 Sep; 383(6595):60-2. PubMed ID: 8779715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transition-state ensemble in enzyme catalysis: possibility, reality, or necessity?
    Ma B; Kumar S; Tsai CJ; Hu Z; Nussinov R
    J Theor Biol; 2000 Apr; 203(4):383-97. PubMed ID: 10736215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Theoretical investigation of the origins of catalysis of a retro-Diels-Alder reaction by antibody 10F11.
    Leach AG; Houk KN; Reymond JL
    J Org Chem; 2004 May; 69(11):3683-92. PubMed ID: 15152997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contributions of long-range electrostatic interactions to 4-chlorobenzoyl-CoA dehalogenase catalysis: a combined theoretical and experimental study.
    Wu J; Xu D; Lu X; Wang C; Guo H; Dunaway-Mariano D
    Biochemistry; 2006 Jan; 45(1):102-12. PubMed ID: 16388585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Theoretical study of catalytic efficiency of a Diels-Alderase catalytic antibody: an indirect effect produced during the maturation process.
    Martí S; Andrés J; Moliner V; Silla E; Tuñón I; Bertrán J
    Chemistry; 2008; 14(2):596-602. PubMed ID: 17960540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catalytic antibody activity elicited by active immunisation. Evidence for natural variation involving preferential stabilization of the transition state.
    Gallacher G; Jackson CS; Searcey M; Goel R; Mellor GW; Smith CZ; Brocklehurst K
    Eur J Biochem; 1993 May; 214(1):197-207. PubMed ID: 8508792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The structural and functional basis of antibody catalysis.
    Wade H; Scanlan TS
    Annu Rev Biophys Biomol Struct; 1997; 26():461-93. PubMed ID: 9241427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystallographic and biochemical analysis of cocaine-degrading antibody 15A10.
    Larsen NA; de Prada P; Deng SX; Mittal A; Braskett M; Zhu X; Wilson IA; Landry DW
    Biochemistry; 2004 Jun; 43(25):8067-76. PubMed ID: 15209502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanistic analysis of the phosphonate transition-state analogue-derived catalytic and non-catalytic antibody.
    Nishi Y; Yamamoto N; Shimazaki K; Takahashi-Ando N; Kakinuma H; Jialin S; Ruzheinikov SN; Muranova TA; Rice DW; Kajihara Y
    J Biochem; 2007 Oct; 142(4):421-33. PubMed ID: 17981825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies.
    Ulrich HD; Schultz PG
    J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First-principle studies of intermolecular and intramolecular catalysis of protonated cocaine.
    Zhan CG; Deng SX; Skiba JG; Hayes BA; Tschampel SM; Shields GC; Landry DW
    J Comput Chem; 2005 Jul; 26(10):980-6. PubMed ID: 15880781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonspecific medium effects versus specific group positioning in the antibody and albumin catalysis of the base-promoted ring-opening reactions of benzisoxazoles.
    Hu Y; Houk KN; Kikuchi K; Hotta K; Hilvert D
    J Am Chem Soc; 2004 Jul; 126(26):8197-205. PubMed ID: 15225061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereoselectivity behavior of the AZ28 antibody catalyzed oxy-Cope rearrangement.
    Martí S; Andrés J; Moliner V; Silla E; Tuñón I; Bertrán J
    J Phys Chem A; 2006 Jan; 110(2):726-30. PubMed ID: 16405346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complete reaction cycle of a cocaine catalytic antibody at atomic resolution.
    Zhu X; Dickerson TJ; Rogers CJ; Kaufmann GF; Mee JM; McKenzie KM; Janda KD; Wilson IA
    Structure; 2006 Feb; 14(2):205-16. PubMed ID: 16472740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.